47
Views
12
CrossRef citations to date
0
Altmetric
Review

Recent developments in antitumour taxoids

, &
Pages 1809-1823 | Published online: 02 Mar 2005

Bibliography

  • DA ROCHA AB, LOPES PM, SCHWARTSMANN G: Natural products in anticancer therapy. Curt: Opin. Pharmacol (2001) 1:364–369.
  • WANT MC, TAYLOR HL, WALL ME, COGGON P, MCPHAIL AT: Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia Am. Chem. Soc. (1971) 93:2325–2327.
  • GUERITTE-VOEGELEIN F, GUENARD D, MANGATAL L et al: Structure of a synthetic taxol precursor: N-tert-butoxycarbony1-10-deacetyl-N-debenzoyltaxol Acta Cyst. (1990) C46:781–784.
  • SCHIFF PB, FANT J, HORVVITZ SB: Promotion of microtubules assembly in vitro by taxol. Nature (1979) 277:665–667.
  • GUERITTE-VOEGELEIN F, GUENARD D, LAVELLE F, LEGOFF MT, MANGATAL L, POTTER P: Relationships between the structure of taxol analogues and their antimitotic activity. I Med. Chem. (1991) 34:992–998.
  • NOGALES E, WOLF SG, DOWNING KH : Structure of the al3 tubulin dimer by electron cristallography. Nature (1998) 391:199–202.
  • LOWE J, DOWNING KH, NOGALES E: Refined structure of al3 tubulin at 3.5 A resolution. J. Ma Biol. (2001) 313:1045–1057.
  • SNYDER PJ, NETTLES JH, CORNETT B, DOWNING KH, NOGALES E: The binding conformation of Taxol ° in 3-tubulin: a model based on electron crystallographic density. Proc. Natl. Acad. ScL USA (2001) 98:5312–5313.
  • UN S, OJIMA I: Recent strategies in the development of taxane anticancer drugs. Expert Opin. The]: Patents (2000) 10:869–889.
  • •A review of patent literature concerning antiturnour taxoids for the period 1997-1999.
  • BALOGLU E, KINGSTON DGI: The taxane diterpenoids. Nat. Prod.(1999) 62:1448–1472.
  • HOLTON RA, KIM HB, SOMOZA C et al.: First total synthesis of taxol 2. Completion of the C and D rings. I Am. Chem. Soc. (1994) 116:1599–1600.
  • NICOLAOU KC, YANG Z, LIU JJ et al.:First total synthesis of taxol. Nature (1994) 367:630–634.
  • DANISHEFSKY SJ, MASTERS JJ, YOUNG WB et al.: Total synthesis of baccatin III and taxol. ./. Am. Chem. Soc. (1996) 118:2843–2859.
  • WENDER PA, BADHAM NE CONWAY SP et al.: The pinene path to taxanes 6. A concise stereocontrolled synthesis of taxol. ./. Am. Chem. Soc. (1997) 119:2757–2758.
  • MORIHIRA K, RYOMA H, KAWAHARA S et al.: Enantioselective total synthesis of taxol. J. Am. Chem. Soc. (1998) 120:12980–12981.
  • MUKAIYAMA T, SHIINA I, IWADARE H et al.: Asymmetric total synthesis of taxol. Chem-EuL (1999) 5:121–161.
  • KUSAMA H, HARA R, KAWAHARA S et al. Enantioselective total synthesis of (-)-taxol. .[ Am. Chem. Soc. (2000) 122:3811–3820.
  • DENTS JN, GREENE AE, GUENARD D, GUERITTE-VOEGELEIN F, MANGATAL L, POTTER P: Highly efficient, practical approach to natural taxol. J.Am.Chem.Soc. (1988) 110:5917–5919.
  • COMMERCON A, BOURZAT JD, DIDIER E, LAVELLE F: Practical semisynthesis and antimitotic activity of docetaxel and side-chain analogues. In: Taxane Anti-Cancer Agents: Basic Science and Current Status. GI Georg, TT Chen, I Ojima, DM Vyas (Eds), ACS Symposium Series, American Chemical Society, Washington, DC, USA (1995):233–246.
  • OJIMA I, HABUS I, ZHAO M et al.: New and efficient approaches to the semisynthesis of taxol and its C-13 side chain analogs by means of B-lactam synthon method. Tetrahedron (1992) 48:6985–7012.
  • HOLTON RA, BIEDEGER RJ, BOATMAN PD: Semisynthesis of taxol and taxotere. In: Science and applications. M Suffness (Ed.), CRC Press, Boca Raton, FL, USA (1995):97–121.
  • MANGATAL L, ADELINE MT, GUENARD D, GUERITTE-VOEGELEIN F, POTTER P: Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analogues. Tetrahedron (1989) 45:4177–4190.
  • APPENDINO G: Naturally occurring taxoids. In: The Chemistry, and Pharmacology of Taxol° and its derivatives. V Farina (Ed.), Elsevier (1995):7–53.
  • CHAUVIERE G, GUENARD D, PICOT V, SENILH V, POTTER P: Analyse structurale et etude biochimique de produits isolés deComptes RendusAcad. ScL Paris Se]: 11 (1981) 293:501-503.
  • SENILH V, BLECHERT S, COLIN M, GUENARD D, PICOTF, POTTER P, VARENNE P: New analogs of taxol extracts from Taxus baccata.f. Nat. Prod. (1984) 47:131–137.
  • McLAUGHLIN JL, MILLER RW, POWELL RW, POWELL RG, SMITH CR Jr: 19-Hydroxybaccatin III, 10-deacetylcaphalomannine and 10-deacetyltaxol: new antitumor taxanes from Taxus wallichiana. j Nat. Prod (1981) 44:312–319.
  • KINGSTON DG, HAWKINS DR, OVINGTON L: New taxanes from Taxus brevifolia. Nat. Prod. (1982) 45:466–470.
  • ZHONG JJ: Plant cell culture for production of paclitaxel and other taxanes. Biosci. Bioeng. (2002) 94:591–599.
  • STIERLE A, STROBEL G, STIERLE D: Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of pacific yew. Science (1993) 260:214–216.
  • WALKER K, CROTEAU R: Taxol biosynthetic genes. Phytochemismy (2001) 58:1–7.
  • •Recent review on the genes responsible for the biosynthesis of paditaxel.
  • GUENARD D, GUERITTE-VOEGELEIN F, POTTER P: Taxol and taxotere: discovery, chemistry, and structure-activity relationships. Acc. Chem. Res. (1993) 26:160–167.
  • KINGSTON DGI, CHAUDHARY AG, GUNATILAKA AAL, MIDDLETON ML: Synthesis of taxol from baccatin via an oxazoline intermediate. Tetrahedron Lett. (1994) 35:4483–4484.
  • GENNARI C, CARCANO M, DONGHI M et al.: Taxol semisynthesis: a highly enantio- and diastereoselective synthesis of the side chain and a new method for ester formation at C-13 using thioesters. Org. Chem. (1997) 62:4746–4755.
  • BALOGLU E, KINGSTON DGI: A new semisynthesis of paclitaxel from baccatin III. Nat. Prod. (1999) 62:1068–1071.
  • ROWINSKI EK: The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Ann. Rev Med. (1997) 48:353–374.
  • APPENDINO G, DANIELI B, JAKUPOVICJ, BELLORO E, SCAMBIA G, BOMBARDELLI E: Synthesis and evaluation of C-secopaclitaxel analogues. 7etrahedron Lett. (1997) 38:4273–4276.
  • CHEN SH, WET JM, LONG BH et al.: Novel C-4 paclitaxel (Taxoll analogs: potent anitumor agents. Bioorg. Med. Chem. Lett. (1995) 5:2741–2746.
  • POLIZZI D, PRATESI G, MONESTIROLI S et at Oral efficacy and bioavailability of a novel taxane. Chit. Cancer Res. (2000) 6:2070–2074.
  • OJIMA I, UN S, WANG T: Recent advances in the medicinal chemistry of taxoids with novel I3-amino acid side chains. Carr: Med. Chem. (1999) 6:927–954.
  • OJIMA I, WANG T, MILLER ML, UN S et al.: Synthesis and structure-activity relationships of new second-generation taxoids. Bioorg. Med. Chem. Lett. (1999) 9:3423–3428.
  • OJIMA I, SLATER JC, MICHAUD E et al.: Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells.' Med. Chem. (1996) 39:3889–3896.
  • OJIMA I, UN S : Efficient asymetric syntheses of I3-lactams bearing a cyclopropane or an epoxide moiety and their application to the syntheses of novel isoserines and taxoids. J. Org. Chem. (1998) 63:224–225.
  • MO Y, GAN Y, SONG SH et al: Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Cancer Res. (2003) 63:579–585.
  • •Experiments showing that combined use of agents targeting both telomere and telomerase, such as AZT and paclitaxel, yields synergistic activity selective for tumours.
  • BRUEGGEMEIR RW: Overview of the pharmacology of the aromatase inactivator exemestane. Breast Cancer Res. Treat. (2002) 4:177–185.
  • TAGLIARINO C, PINK JJ, DUBYAK GR,NIEMINEN AL, BOOTHMAN DA: Calcium is a key signaling molecule in P-lapachone-mediated cell death. Biol. Chem. (2001) 276:19150–19159.
  • SELZNER M, BIELAWSKA A, MORSE MA et al.: Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. (2001) 61:1233–1240.
  • BEAVO JA: Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiological Rev. (1995) 75:725–747.
  • BOUCHARD H, PULICANI JP, VUILHORGNE M, BOURZAT JD, COMMERON A: Improved access to 19-nor-713,8B-methylene-taxoids and formation of a 7-membered C-ring analog of docetaxel. Tetrahedron Lett. (1994) 35:9713–9716.
  • ALTSTADT TJ, FAIRCHILD CR, GOLIK J et al.: Synthesis and antitumor activity of novel C-7 paclitaxel ethers: discovery of BMS-184476. j Med. Chem. (2001) 44:4577–4583.
  • OJIMA I, GENG X, WU X et al.: Tumor-specific novel taxoid-monoclonal antibody conjugates. Med. Chem. (2002) 45:5620–5623.
  • BELOTTI D, VERGANI V, DRUDIS T et al.: The microtubule-affecting drug paclitaxel has antiangiogenic activity. Gin. Cancer Res. (1996) 2:1843–1849.
  • •Data showing that paclitaxel has a strong antiangiogenic activity.
  • WHELAN J: Targeted taxane therapy for cancer. Drug Discov. Today(2002) 7:90–92.
  • •A review concerning taxoid conjugates that are delivered to the tumour site. We thank one of the referees for this information.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.